Рет қаралды 4,730
Imagine a future where schizophrenia isn't just managed, but potentially healed. That's what Stephen and his dad, Steve, explore in this episode of Surviving Schizophrenia. They dive deep into the world of regenerative brain therapy and a revolutionary medication called SPG302, currently in phase two clinical trials in Australia.
Stephen opens up about his personal journey with schizophrenia, a journey that drastically altered his life 13 years ago. He went from being a straight-A student to struggling with basic math and focus after his illness began. He shares the challenges of living with debilitating negative symptoms like social withdrawal, lack of concentration, and cognitive difficulties that make everyday life, including holding a job, incredibly tough.
Steve, Stephen's dedicated father and support person, brings a unique perspective. He discusses regenerative therapy and how connections (synapses) in the brain can be damaged by schizophrenia. SPG302 aims to repair those broken connections, potentially restoring cognitive function and improving quality of life.
Stephen paints a vivid picture of his hopes for the future with this therapy. He dreams of regaining his cognitive abilities, securing a job, and being more productive. He even envisions a life where he can reduce his medication and overcome the challenges of misophonia, a condition that makes him overly sensitive to certain sounds.
This video isn't just about a new medication; it's about hope and the potential for a brighter future for those living with schizophrenia. Stephen and Steve's genuine optimism is truly inspiring.
Want to learn more about this groundbreaking research? We've included links in the description to articles about SPG302 and regenerative therapy for schizophrenia.
Join the Surviving Schizophrenia community! Subscribe to Stephen’s channel for more personal stories, informative discussions, and the latest updates on schizophrenia treatments.
We want to hear from you! Share your thoughts on regenerative therapy in the comments below. What are your hopes for the future of schizophrenia treatment?
----
PSYCHIATRIC TIMES: www.psychiatri...
Synaptic Regenerative Therapy
Synaptic Regenerative Therapy, using drugs like SPG302, represents a novel approach to treating schizophrenia by focusing on regenerating lost synapses in the brain. This is a significant departure from current antipsychotic medications, which primarily target dopamine receptors to manage symptoms, but often fall short in addressing negative and cognitive symptoms, and may not work for all patients.
SPG302 specifically targets glutamatergic synapses, the primary excitatory connections between neurons, which are believed to be diminished in individuals with schizophrenia. By restoring these crucial communication pathways, SPG302 aims to reverse a core anatomical deficit thought to underlie the various symptom domains of schizophrenia, including positive symptoms (hallucinations, delusions), negative symptoms (social withdrawal, apathy), and cognitive impairments (memory and attention problems).
As of October 31, 2024, SPG302 is undergoing Phase 2 clinical trials in Australia to evaluate its safety, efficacy, tolerability, and pharmacodynamics in individuals diagnosed with schizophrenia.
#schizophrenia #mentalhealth #regenerativetherapy #braintheapy #SPG302 #survivingschizophrenia #mentalillness #cognitivesymptoms #negativesymptoms #psychosis #recovery #hope #clinicaltrials #newtreatment #neuroscience #brainhealth #misophonia #supportperson